• The power of local knowledge
    on a global scale.

    No matter where your clinical development takes you, we're already there. Where are you today?

  • We are dedicated to
    the future of clinical development
    and to every life it saves.

    Learn more about why we do what we do, and what we can do for you. Click to read our story.

  • There's just no denying
    good chemistry

    Explore the PRA HEALTH SCIENCES interactive experience to find out what makes us tick.

Social Media

See the latest interactions from our social media

Google+

At PRA, our commitment to help bring life-saving #cancer treatment to market is evident in the access...


View Post

Featured News

Read the latest updates from our PR department

PRA Sponsors Russian Regional Quality Assurance Forum

12 May 2015, Raleigh, NC – PRA Health Sciences (PRA) is pleased to sponsor the first meeting of Quality Assurance (QA) experts in Russia. The Russian Regional Research Quality Association...

PRA Health Sciences, Inc. Reports First Quarter 2015 Results

$332.0 million of service revenue in the first quarter; 10% constant currency service revenue growth compared to the first quarter of 2014

• $55.7 million of Adjusted EBITDA in the first...

PRA is Named International Clinical Company of the Year

27 April 2015, Raleigh, N.C. – PRA Health Sciences (PRA) is pleased to announce that it was named Clinical Company of the Year at the International Clinical Researcher of the Year award...

Read More >

Media Resources

Explore the latest resources uploaded to our media library

Sign Up for PRA's Industry Watch

Brought to you by PRA Health Sciences. A Bi-Weekly Industry Watch Newsletter

CASE STUDY: PRA Feasibility Leads To Unique Enrollment Strategy

PRA recently performed a feasibility study to identify investigators who see patients with a rare neuromuscular autoimmune disease and who have the capability to perform a Phase II clinical trial.

FACT SHEET: CNS

PRA Health Sciences provides our clients with innovative solutions for CNS (neurology, psychiatry, and pain) drug development. Our work spans from early phase development to NDA and MAA submissions...

CASE STUDY: PRA Teamwork Demonstrates Vision

A large pharmaceutical client selected PRA to conduct 2 Phase III epilepsy studies in India, Eastern and Western Europe, and Australia. PRA’s project teams surpassed recruitment goals and achieved timely site activations despite administrative delays and tough competition for volunteers.

Events

Find out what's happening next on PRA's event schedule

ASCO ANNUAL MEETING
May 29 - June 2

The ASCO Annual Meeting brings together 30,000 oncology professionals from around the world. Educational sessions feature world-renowned faculty discussing state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field. Science sessions present the latest ground-breaking research in oral and poster format. You’ll meet friends and make connections, and bring back new ideas to your […]

63RD ASMS CONFERENCE ON MASS SPECTROMETRY AND ALLIED TOPICS
May 31 - June 4

All conference sessions and short courses was held at the America’s Center Convention Complex, 701 Convention Plaza, St Louis, MO 63101. The conference program is coordinated by Vicki Wysocki (VP Programs), The Ohio State University. The schedule begins on Sunday, May 31 with tutorial lectures at 5:00 pm and the opening session and plenary lecture […]

EXPLORATORY CLINICAL DEVELOPMENT WORLD EUROPE
June 2 - June 3

The 9th annual Exploratory Clinical Development World Europe brings together early stage clinical, safety and pharmacology decision makers and influencers. Join them as they brainstorm approaches to improving translatability, developability, and optimising the medical value of products in early stage trials.

Read More >